VIA Pharmaceuticals (VIAP) Stock Price, Quote, News & History

Comments

VIA Pharmaceuticals Inc (VIAP) Stock Price, Quote, News & History

VIAPOTCEM

Trade with Public

$0.000001

N/A

At close: Dec 30, 4:00 PM EST

OverviewNews

Key Statistics

Open

$0.00

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$20.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent VIA Pharmaceuticals Inc News

Stocks That Hit 52-Week Highs On Friday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.11M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

4.00M

Free Cash Flow (TTM)

-6.11M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.11M

Valuation Metrics

Enterprise Value

$226.14K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$14.00M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$84.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.00

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$20.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

VIA Pharmaceuticals Inc is a development stage biotechnology company focuses on the development of small-molecule drugs to treat cardiovascular and metabolic diseases.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy VIA Pharmaceuticals (VIAP) stock?

You can purchase shares of VIA Pharmaceuticals (OTCEM:VIAP) through any online brokerage.

View our list of the best stock brokerages

Who are VIA Pharmaceuticals (VIAP) competitors?

There are no as such competitors for VIA Pharmaceuticals.

What is the forecast, or price target, for VIA Pharmaceuticals (VIAP) stock?

There is no analysis for VIA Pharmaceuticals to provide a consensus price target.

What is the current price for VIA Pharmaceuticals (VIAP)?

The stock price for VIA Pharmaceuticals (OTCEM: VIAP) is $0.000001 last updated April 24, 2025 at 12:09 PM EDT.

Does VIA Pharmaceuticals (VIAP) pay a dividend?

There are no upcoming dividends for VIA Pharmaceuticals.

When is VIA Pharmaceuticals (OTCEM:VIAP) reporting earnings?

VIA Pharmaceuticals does not have any upcoming earnings scheduled.

Is VIA Pharmaceuticals (VIAP) going to split?

There is no upcoming split for VIA Pharmaceuticals.

What sector and industry does VIA Pharmaceuticals (VIAP) operate in?

VIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.

Key Statistics

Open

$0.00

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$20.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent VIA Pharmaceuticals Inc News

Stocks That Hit 52-Week Highs On Friday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-6.11M

Investing Cash Flow (TTM)

Financing Cash Flow (TTM)

4.00M

Free Cash Flow (TTM)

-6.11M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-2.11M

Valuation Metrics

Enterprise Value

$226.14K

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$14.00M

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$84.00K

Debt to Equity

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.00

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

0.00 - 0.00

Market Cap

$20.00

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

VIA Pharmaceuticals Inc is a development stage biotechnology company focuses on the development of small-molecule drugs to treat cardiovascular and metabolic diseases.

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy VIA Pharmaceuticals (VIAP) stock?

You can purchase shares of VIA Pharmaceuticals (OTCEM:VIAP) through any online brokerage.

View our list of the best stock brokerages

Who are VIA Pharmaceuticals (VIAP) competitors?

There are no as such competitors for VIA Pharmaceuticals.

What is the forecast, or price target, for VIA Pharmaceuticals (VIAP) stock?

There is no analysis for VIA Pharmaceuticals to provide a consensus price target.

What is the current price for VIA Pharmaceuticals (VIAP)?

The stock price for VIA Pharmaceuticals (OTCEM: VIAP) is $0.000001 last updated April 24, 2025 at 12:09 PM EDT.

Does VIA Pharmaceuticals (VIAP) pay a dividend?

There are no upcoming dividends for VIA Pharmaceuticals.

When is VIA Pharmaceuticals (OTCEM:VIAP) reporting earnings?

VIA Pharmaceuticals does not have any upcoming earnings scheduled.

Is VIA Pharmaceuticals (VIAP) going to split?

There is no upcoming split for VIA Pharmaceuticals.

What sector and industry does VIA Pharmaceuticals (VIAP) operate in?

VIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.